The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Title |
Clinical Utility of Mobocertinib in the Treatment of NSCLC – Patient Selection and Reported Outcomes
|
---|---|
Published in |
OncoTargets and therapy, July 2023
|
DOI | 10.2147/ott.s374489 |
Pubmed ID | |
Authors |
Abram Arnold, Apar Kishor Ganti |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 1 | 50% |
Unknown | 1 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 1 | 50% |
Unknown | 1 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2023.
All research outputs
#23,513,156
of 26,180,352 outputs
Outputs from OncoTargets and therapy
#2,104
of 3,021 outputs
Outputs of similar age
#322,891
of 378,191 outputs
Outputs of similar age from OncoTargets and therapy
#10
of 14 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,021 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 378,191 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.